{"basic_info": {"ticker": "603676", "exchange": "XSHG", "bloomberg_ticker": "603676 CH Equity", "name": "TIBET WEIXINKANG MEDICINE -A", "industry": "Pharmaceuticals", "name_chinese_simplified": "卫信康", "period": "2020", "market_value": 3802769920, "total_income": 740963155, "ccy": "人民币元", "shariah_compliance_summary": "unknown"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 283407468, "business_income_over_total_income": 0.3824852370695814}, {"shariah_compliance": "unknown", "income": 457555684, "business_income_over_total_income": 0.6175147588816342}], "details": [{"business_activity_cn": "静脉补充维生素用药", "business_activity_en": "Intravenous drug use vitamin supplements", "income": 37713019, "business_income_over_total_income": 0.050897293266896654, "shariah_compliance": "compliant"}, {"business_activity_cn": "电解质补充药", "business_activity_en": "Electrolyte supplements medicine", "income": 218851622, "business_income_over_total_income": 0.29536100482621164, "shariah_compliance": "compliant"}, {"business_activity_cn": "静脉补铁用药", "business_activity_en": "Intravenous iron administration", "income": 8450146, "business_income_over_total_income": 0.011404272861583785, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他药品", "business_activity_en": "Other drugs", "income": 18392681, "business_income_over_total_income": 0.02482266611488934, "shariah_compliance": "compliant"}, {"business_activity_cn": "服务性收入", "business_activity_en": "Service income", "income": 457415927, "business_income_over_total_income": 0.6173261435651277, "shariah_compliance": "unknown"}, {"business_activity_cn": "其他业务", "business_activity_en": "Other business", "income": 139757, "business_income_over_total_income": 0.00018861531650652723, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.000758815772913584, "shariah_compliance": "compliant", "amount_over_market_value": 0.000758815772913584}]}